Lingying Wu

3.2k total citations
206 papers, 1.7k citations indexed

About

Lingying Wu is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Lingying Wu has authored 206 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Reproductive Medicine, 68 papers in Oncology and 67 papers in Obstetrics and Gynecology. Recurrent topics in Lingying Wu's work include Ovarian cancer diagnosis and treatment (71 papers), Endometrial and Cervical Cancer Treatments (65 papers) and Cervical Cancer and HPV Research (27 papers). Lingying Wu is often cited by papers focused on Ovarian cancer diagnosis and treatment (71 papers), Endometrial and Cervical Cancer Treatments (65 papers) and Cervical Cancer and HPV Research (27 papers). Lingying Wu collaborates with scholars based in China, United States and Taiwan. Lingying Wu's co-authors include Ning Li, Jusheng An, Jia Zeng, Leilei Liang, Xiaoguang Li, Jian Li, Bin Li, Hong‐Tu Zhang, Tiantian Wang and Wen‐Hua Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Lingying Wu

196 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingying Wu China 21 523 517 482 454 352 206 1.7k
Yasuyuki Hirashima Japan 26 557 1.1× 362 0.7× 542 1.1× 455 1.0× 406 1.2× 81 1.8k
Rebecca Brooks United States 19 664 1.3× 482 0.9× 439 0.9× 723 1.6× 216 0.6× 49 1.8k
Yoshihiro Ohishi Japan 24 529 1.0× 594 1.1× 491 1.0× 459 1.0× 165 0.5× 84 1.7k
Salvatore Lopez Italy 25 369 0.7× 619 1.2× 551 1.1× 606 1.3× 183 0.5× 89 1.6k
Danhua Shen China 23 477 0.9× 295 0.6× 454 0.9× 283 0.6× 249 0.7× 150 1.9k
Eliane Mery-Lamarche France 23 333 0.6× 431 0.8× 579 1.2× 587 1.3× 471 1.3× 64 1.7k
Wataru Yamagami Japan 24 473 0.9× 703 1.4× 641 1.3× 763 1.7× 349 1.0× 124 2.0k
Arto Leminen Finland 28 415 0.8× 590 1.1× 538 1.1× 651 1.4× 293 0.8× 60 1.9k
Eirini Pectasides Greece 24 617 1.2× 600 1.2× 621 1.3× 354 0.8× 289 0.8× 49 1.8k
Marta A. Crispens United States 25 568 1.1× 723 1.4× 498 1.0× 447 1.0× 296 0.8× 62 1.8k

Countries citing papers authored by Lingying Wu

Since Specialization
Citations

This map shows the geographic impact of Lingying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingying Wu more than expected).

Fields of papers citing papers by Lingying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingying Wu. The network helps show where Lingying Wu may publish in the future.

Co-authorship network of co-authors of Lingying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingying Wu. A scholar is included among the top collaborators of Lingying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingying Wu. Lingying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xinyu, et al.. (2025). Research Progress on the Treatment of Related Diseases With Astragalus. Drug Design Development and Therapy. Volume 19. 2845–2862.
2.
Wu, Lingying, Xiaofan Li, Mei Feng, et al.. (2024). Efficacy and safety of enlonstobart (SG001), a PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer: A multicenter, single-arm, open-label, phase II study.. Journal of Clinical Oncology. 42(16_suppl). 5526–5526. 4 indexed citations
3.
4.
Zhao, Haobin, Yuxiang Ma, Xiao‐Ming Meng, et al.. (2024). 605O YL201, a novel B7H3-targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors: Results from a first-in-human phase I study. Annals of Oncology. 35. S485–S485. 4 indexed citations
5.
Yuan, Hua, et al.. (2024). PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of Gynecologic Oncology. 35(4). e51–e51. 1 indexed citations
6.
Wu, Lingying, Qingshui Li, Jundong Li, et al.. (2024). A phase III randomized, double-blinded, placebo-controlled study of suvemcitug combined with chemotherapy for platinum-resistant ovarian cancer (SCORES).. Journal of Clinical Oncology. 42(17_suppl). LBA5516–LBA5516.
7.
Ou, Shih‐Hsiang, et al.. (2023). Diabetic Macular Edema Is Predictive of Renal Failure in Patients With Diabetes Mellitus and Chronic Kidney Disease. The Journal of Clinical Endocrinology & Metabolism. 109(3). 761–770. 2 indexed citations
8.
9.
Li, Wenbin, Xin Yi, Leming Shi, et al.. (2023). Patient Assessment and Therapy Planning Based on Homologous Recombination Repair Deficiency. Genomics Proteomics & Bioinformatics. 21(5). 962–975. 5 indexed citations
10.
Yu, Jing, Tingting Liu, Leilei Liang, et al.. (2021). Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Cancer Cell International. 21(1). 353–353. 21 indexed citations
11.
12.
13.
Song, Yan, et al.. (2016). [Relationship between P53 Protein Expression and Prognosis of Advanced Ovarian Serous Adenocarcinoma].. PubMed. 38(2). 169–74. 1 indexed citations
14.
Wang, Ziyi, Lingying Wu, Hongwen Yao, et al.. (2015). [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].. PubMed. 50(3). 198–203. 7 indexed citations
15.
Han, Ying, Shumin Li, Lingying Wu, Xun Zhang, & Dengfeng Cao. (2015). Non‐Peutz‐Jeghers syndrome‐associated ovarian sex cord tumor with annular tubules: Report of a malignant case. Journal of obstetrics and gynaecology research. 42(2). 224–227. 8 indexed citations
16.
Zhao, Dan, Lingying Wu, Xiaobing Wang, & Xiaoguang Li. (2015). Role of Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer. Asian Pacific Journal of Cancer Prevention. 16(6). 2369–2373. 6 indexed citations
17.
Li, Lin, Ying Zhang, Ning Li, et al.. (2014). Nidogen-1: a candidate biomarker for ovarian serous cancer. Japanese Journal of Clinical Oncology. 45(2). 176–182. 22 indexed citations
18.
Wu, Lingying, et al.. (2012). [Analysis of 25 cases of brain metastasis from gynecological cancers].. PubMed. 47(3). 191–5. 2 indexed citations
19.
Li, Bin, et al.. (2008). [A prospective study on nerve-sparing radical hysterectomy in patients with cervical cancer].. PubMed. 43(8). 606–10. 9 indexed citations
20.
Zhang, Hong‐Tu, et al.. (2005). [Border-line smooth-muscle tumor of the uterus: analysis of 131 patients].. PubMed. 27(11). 698–700. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasuyuki Hirashima Breakdown of academic impact, for papers by Rebecca Brooks Breakdown of academic impact, for papers by Yoshihiro Ohishi Breakdown of academic impact, for papers by Salvatore Lopez Breakdown of academic impact, for papers by Danhua Shen Breakdown of academic impact, for papers by Eliane Mery-Lamarche Breakdown of academic impact, for papers by Wataru Yamagami Breakdown of academic impact, for papers by Arto Leminen Breakdown of academic impact, for papers by Eirini Pectasides Breakdown of academic impact, for papers by Marta A. Crispens
Rankless by CCL
2026